Brainsway (BWAY) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BrainsWay reported a strong 26% revenue growth in Q3 2024, raising its full-year revenue guidance to $40-41 million and achieving net income of $0.7 million. The company plans to leverage a recent $20 million equity financing for strategic initiatives and market expansion. BrainsWay continues to advance its Deep TMS technology, with increased system deployments and ongoing clinical trials, enhancing its leadership in mental health treatment innovations.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
